You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 5, May 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (99)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Dementias
 •Neuropathology
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Inflammatory Proteins in Plasma and the Risk of Dementia

The Rotterdam Study

Marianne J. Engelhart, MD, PhD; Mirjam I. Geerlings, PhD; John Meijer, MSc; Amanda Kiliaan, PhD; Annemieke Ruitenberg, MD, PhD; John C. van Swieten, MD, PhD; Theo Stijnen, PhD; Albert Hofman, MD, PhD; Jacqueline C. M. Witteman, PhD; Monique M. B. Breteler, MD, PhD

Arch Neurol. 2004;61:668-672.

Background  Increased levels of inflammatory proteins have been found in the brains and plasma samples of patients with dementia. Whether the levels of inflammatory proteins in plasma samples are elevated before clinical onset of dementia is unclear.

Objective  To determine whether high levels of inflammatory proteins in plasma samples are associated with an increased risk of dementia.

Design and Setting  A case-cohort study within the Rotterdam Study, a population-based prospective cohort study in the Netherlands.

Participants  The source population comprises 6713 subjects who, at baseline (1990-1993), were free of dementia and underwent venipuncture. From these, we selected both a random subcohort of 727 subjects and 188 cases who had developed dementia at follow-up.

Main Outcome Measures  The associations between plasma levels of {alpha}1-antichymotrypsin, C-reactive protein, interleukin 6, the soluble forms of intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 and the risk of dementia were examined using the Cox proportional hazards regression models.

Results  High levels of {alpha}1-antichymotrypsin, interleukin 6, and, to a lesser extent, C-reactive protein were associated with an increased risk of dementia; rate ratios per standard deviation increase were 1.49 (95% confidence interval, 1.23-1.81), 1.28 (95% confidence interval, 1.06-1.55), and 1.12 (95% confidence interval, 0.99-1.25), respectively. Similar associations were observed for Alzheimer disease, whereas rate ratios of vascular dementia were higher for {alpha}1-antichymotrypsin and C-reactive protein. Soluble forms of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 were not associated with dementia.

Conclusion  Plasma levels of inflammatory proteins are increased before clinical onset of dementia, Alzheimer disease, and vascular dementia.


From the Departments of Epidemiology and Biostatistics (Drs Engelhart, Geerlings, Ruitenberg, Stijnen, Hofman, Witteman, and Breteler) and Neurology (Drs Ruitenberg and van Swieten), Erasmus Medical Center, Rotterdam, the Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht (Dr Geerlings), Numico Research, Wageningen (Dr Kiliaan and Mr Meijer), and the Department of Anatomy, University Medical Center, Nijmegen (Dr Kiliaan), the Netherlands.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mouths and brains. Could oral infection be a risk factor for dementia?
Stewart
J. Neurol. Neurosurg. Psychiatry 2009;80:1184-1184.
FULL TEXT  

Inflammatory Biomarkers of Vascular Risk as Correlates of Leukoariosis
Wright et al.
Stroke 2009;40:3466-3471.
ABSTRACT | FULL TEXT  

Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk
Devore et al.
Am. J. Clin. Nutr. 2009;90:170-176.
ABSTRACT | FULL TEXT  

Predictors of maintaining cognitive function in older adults: The Health ABC Study
Yaffe et al.
Neurology 2009;72:2029-2035.
ABSTRACT | FULL TEXT  

The relationship between type 2 diabetes and dementia
Strachan et al.
Br Med Bull 2008;88:131-146.
ABSTRACT | FULL TEXT  

Oral Health and Cognitive Function in the Third National Health and Nutrition Examination Survey (NHANES III)
Stewart et al.
Psychosom. Med. 2008;70:936-941.
ABSTRACT | FULL TEXT  

Plasma Amyloid {beta}-Protein and C-reactive Protein in Relation to the Rate of Progression of Alzheimer Disease
Locascio et al.
Arch Neurol 2008;65:776-785.
ABSTRACT | FULL TEXT  

Serum Albumin Levels Predict Cognitive Impairment in Elderly Hip Fracture Patients
Mizrahi et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2008;23:85-90.
ABSTRACT  

Inflammation and Rate of Cognitive Change in High-Functioning Older Adults
Alley et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2008;63:50-55.
ABSTRACT | FULL TEXT  

Peripheral Inflammatory Biomarkers and Risk of Parkinson's Disease
Chen et al.
Am J Epidemiol 2008;167:90-95.
ABSTRACT | FULL TEXT  

Association of statin use with cognitive decline in elderly African Americans
Szwast et al.
Neurology 2007;69:1873-1880.
ABSTRACT | FULL TEXT  

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies
Nielsen et al.
Neurology 2007;69:1569-1579.
ABSTRACT | FULL TEXT  

Contribution of Metabolic Syndrome Components to Cognition in Older Individuals
Dik et al.
Diabetes Care 2007;30:2655-2660.
ABSTRACT | FULL TEXT  

Increased visceral adipose tissue rather than BMI as a risk factor for dementia
Cereda et al.
Age Ageing 2007;36:488-491.
ABSTRACT | FULL TEXT  

Frailty: An Emerging Research and Clinical Paradigm Issues and Controversies
Bergman et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2007;62:731-737.
ABSTRACT | FULL TEXT  

Serum high sensitivity C-reactive protein and cognitive function in elderly women
Komulainen et al.
Age Ageing 2007;36:443-448.
ABSTRACT | FULL TEXT  

Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study
Jefferson et al.
Neurology 2007;68:1032-1038.
ABSTRACT | FULL TEXT  

C-reactive protein levels predict the incidence of delirium and recovery from it
Macdonald et al.
Age Ageing 2007;36:222-225.
FULL TEXT  

Mediterranean Diet, Alzheimer Disease, and Vascular Mediation
Scarmeas et al.
Arch Neurol 2006;63:1709-1717.
ABSTRACT | FULL TEXT  

Systemic inflammatory markers and risk of dementia.
Dziedzic
AM J ALZHEIMERS DIS OTHER DEMEN 2006;21:258-262.
ABSTRACT  

Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
Galimberti et al.
Arch Neurol 2006;63:538-543.
ABSTRACT | FULL TEXT  

Fibrinogen Is Associated With an Increased Risk of Alzheimer Disease and Vascular Dementia
van Oijen et al.
Stroke 2005;36:2637-2641.
ABSTRACT | FULL TEXT  

Serum inflammatory proteins and cognitive decline in older persons
Dik et al.
Neurology 2005;64:1371-1377.
ABSTRACT | FULL TEXT  

{alpha}1-Antichymotrypsin Gene (SERPINA3) A/T Polymorphism as a Risk Factor for Aneurysmal Subarachnoid Hemorrhage
Slowik et al.
Stroke 2005;36:737-740.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
Yaffe et al.
JAMA 2004;292:2237-2242.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.